Loibner, H; Bauernhofer, T; Samonigg, H; Regitnig, P; Weitzer, W; Lileg, B; Waxenecker, G; Kainer, M; Wiederkum, S; Schuster, M; Kircheis, R.
A phase I/II, open label trial with the Lewis Y specific humanized monoclonal antibody IGN311 in patients with malignant effusions
J IMMUNOTHER. 29(6):634-634.-Meeting Society of Immunotherapy, 21st annual meeting; 26.-29. Oktober 2006; Los Angeles, USA.
[Poster]
Web of Science